Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Kaname Sakuma"'
Autor:
Yuichiro Hayashi, Kenji Mitsudo, Kaname Sakuma, Masaki Iida, Toshinori Iwai, Hideyuki Nakashima, Yoshiyuki Okamoto, Toshiyuki Koizumi, Senri Oguri, Makoto Hirota, Mitomu Kioi, Izumi Koike, Masaharu Hata, Iwai Tohnai
Publikováno v:
Radiation Oncology, Vol 12, Iss 1, Pp 1-8 (2017)
Abstract Background The aim of this retrospective observational study was to evaluate toxicities, overall survival, and locoregional control in elderly oral squamous cell carcinoma patients who had undergone retrograde intra-arterial chemotherapy com
Externí odkaz:
https://doaj.org/article/e1c3ebe21f264bdcb83df5c09ff07ea1
Publikováno v:
Anticancer Research. 42:4273-4283
Although paclitaxel plus cetuximab for recurrent/metastatic oral squamous cell carcinoma (OSCC) has a relatively high success rate, many cases are refractory. We investigated the change in nuclear factor-kappa B (NF-B) expression after this combinati
Autor:
KANAME SAKUMA, TOMOYUKI KII, HARUKA TAKAHASHI, SUSUMU SUZUKI, KAZUHIRO YOSHIKAWA, TETSUYA OGAWA, AKIRA TANAKA
Publikováno v:
Anticancer Research. 42:4293-4303
Autor:
Kaname, Sakuma, Tomoyuki, Kii, Haruka, Takahashi, Susumu, Suzuki, Kazuhiro, Yoshikawa, Tetsuya, Ogawa, Akira, Tanaka
Publikováno v:
Anticancer research. 42(9)
The immunotherapy approach using anti-programmed cell death 1 (PD-1) antibody has been demonstrated in oral cancer treatment. However, serious immune-related adverse events (irAE) have been reported. If local administration of small doses of anti-PD-
Publikováno v:
Journal of Hard Tissue Biology. 30:97-106
Autor:
Junichi Baba, Satomi Sugiyama, Shuji Toya, Senri Oguri, Toshinori Iwai, Kenji Mitsudo, Jun Ueda, Nobuhide Ohashi, Kaname Sakuma, Yasuharu Yajima
Publikováno v:
Japanese Journal of Oral Diagnosis / Oral Medicine. 34:20-24
Publikováno v:
Journal of Hard Tissue Biology. 28:281-288
Autor:
KANAME SAKUMA1 sakuma.k@ngt.ndu.ac.jp, RYUKI TAMURA2, SHINTARO HANYU2, HARUKA TAKAHASHI2, HIDEAKI SATO1, TAKAHIRO ONEYAMA1, AKIRA YAMAGUCHI1, AKIRA TANAKA2
Publikováno v:
Molecular & Clinical Oncology. 2017, Vol. 7 Issue 6, p1021-1026. 6p.
Publikováno v:
Chemotherapy. 65(5-6)
Objective: A combination of the taxane anticancer drug paclitaxel (PTX) and molecular target drug cetuximab (cMab) is effective for the treatment of head and neck squamous cell carcinoma (HNSCC). However, its use is associated with serious side effec
Publikováno v:
Molecular and Clinical Oncology.
Anticancer drug sensitivity testing using the collagen gel droplet embedded culture drug sensitivity test (CD-DST) on oral squamous cell carcinoma (OSCC) samples beginning from 2010 has been conducted. The present study investigated the effect of add